SOURCE: Market Pulse

April 13, 2005 08:30 ET

Market Pulse Breaking News Alert for Wednesday, April 13, 2005: PHBT - Pure H20 Bio-Technologies, Inc. Announces Khandaker Partners, Inc., a New York Research Firm, Updates Market Report of PHBT!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- April 13, 2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Pure H20 Bio-Technologies, Inc. (OTC: PHBT), StemCells Inc. (NASDAQ: STEM), Cisco Systems Inc. (NASDAQ: CSCO), and Owens Corning (OTC BB: OWENQ).

Investors need to be watching Pure H20 Bio-Technologies, Inc. (OTC: PHBT) this AM! PHBT specializes in the manufacturing, design and sale of its unique residential, commercial and hospital point-of-use potable water disinfection systems. These systems are specifically designed to work effectively against water-borne pathogens and remove heavy metals and objectionable biomass. The PHBT technology provides a new water treatment option based on a system designed with both pre-and-post absolute carbon filtration used in combination with direct crystal iodine contact for disinfection. PHBT had great news out in a press release before today's opening bell regarding Khandaker Partners, Inc. updating its investment highlights in its market report! Investors should be watching this one closely!

Pure H20 Bio-Technologies, Inc. (OTCPK: PHBT) today announced that Khandaker Partners, Inc., a N.Y. Research Firm, updated a market report on PHBT. The following Khandaker Market Report is for marketing purposes and consumer awareness. Its content is based on an overview report by Khandaker's Medical Doctors who are senior analysts, leaving a transparent unbiased company highlight and overview based on merit. Khandaker Partners' previous coverage of PHBT can be viewed on the company's website:

About PHBT

PHBT is a publicly-held company specializing in the manufacture, design and sale of its unique residential, commercial and hospital systems that combat waterborne disease.

Following is the updated market report by Khandaker Partners:

Khandaker Partners


Pure H20 Bio-Technologies, Inc (Pink Sheets OTC-BB) Symbol PHBT. Industry: BioTechnology

Investment Highlights:

- Patent pending on Iodine Water Treatment System and Method
- 10% annual growth rate for residential water filtration market
--  Industrial water filtration market valued at $35 billion and growing
    8% annually
--  Receipt of a Letter of Intent from the Export-Import Bank of the
    United States, Washington D.C. for financial support up to $1.5 million for
    its St. John's Antigua Project.
--  Projected revenue Year 1 - $6m, Year 2 - $14m, Year 3 - $21m, Year 4 -
    $34m, Year 5 - $57m
--  Experienced management team merges extensive business experience with
    vast range of scientific knowledge
--  Pure H20 received a letter of intent for up to $1.5 million in
    financing from the Export-Import Bank of the United States, Washington,
    D.C. to support its intended St. John's, Antigua Project. Pure H20 intends
    to ship its equipment and products to Antigua, to help relieve the
    country's perpetual shortage of potable water.
--  Pure H20's water disinfection systems are based on a unique iodine
    disinfection and filtration methodology. The development of the product
    processes and related testing is completed. Using an exclusive leading edge
    iodine storage and dispensing process, in conjunction with granular
    activated carbon filtration.
--  Pure H20 confirmed laboratory tests by Clancy Environmental
    Consultants (CEC), a nationally recognized microbiological/water expert,
    located in St. Albans, Vermont, efficacy of iodine at low concentrations
    reduced the number of microbes by approximately 6 logs (99.9999% killed)
    within 5 minutes and 8 logs (99.999999% killed) within ten minutes. These
    included Escherichia coli, Enterococcus faecalis, and Pseudomonas
    aeruginosa.) CEC has served the United States Environomental Protection
    Agency (EPA), American Waterworks Association (AWA) and private industry in
    an advisory and consultant capacity.
    - Trading Data
      Stock Price: $0.012
      Shs. Outstanding: 49,407,060
      Volume: 2,147,304
      Beta: 0.57
Overview: Pure H20 Bio-Technologies, Inc. ("Pure H20" or "the Company") a Florida corporation, designs, develops, manufactures and markets potable water disinfection systems, particularly medical point-of-use, under-the-counter, whole house and well systems primarily used for commercial and residential applications. Pure H20's unique high-integrity systems address lead, organic, and other contamination such as waterborne disease agents, heavy metals and objectionable biomass. Products can be viewed on the PHBT's website: . The Company utilizes the technological advances in micro-biotechnology to improve the safety of drinking water. Pure H20 has systematically and successfully addressed lead and other chemical and toxicological contamination, as well as waterborne diseases. The Company's decision to utilize iodine in its chemical treatment of water is based upon known properties, including iodine's ability to kill or deactivate all known types of disease-causing, waterborne microorganisms, such as bacteria, viruses and protozoa cysts.

Market: Water Filtration Market: The industrial water filtration market is estimated at $35 billion, and growing 8% annually. The U.S. household water filtration market is $500 million and growing 10% annually. Existing technologies use carbon block filters, reducing microbial contamination, but can't account for the wide array of microorganism diameter depending on their lifecycle. Pure H20's multi-stage system, using absolute micron carbon pre and post filters with controlled release USP iodine, is designed to treat the bacterial pathogens often missed by the two well known home systems. At least 12% of US households treat their drinking water. By 2010, that number is expected to increase to 40%, demonstrating Pure H20's market potential as the demand for high purity water rises rapidly. The Company's strategy focuses on Pure H20 systems' unique ability to provide disinfection in drinking water. Each system component has a specific performance feature that leads to direct benefits for the end user. Pure H20 intends to utilize direct marketing approaches to effectively move the array of water disinfection and treatment products including: direct mail and cable television to enhance the sales efforts of distributors serving the residential market. The Company will utilize combinations of direct contacts along with consulting enginering groups to approach the commercial and resdiential market segments. These markets generally require a professionally designed drinking water system that fits a specific applications and criteria. Under-the-counter and Whole house systems will be marketed primarily through developers and home builders. Offering this product to developers and home builders provides home buyers with the option to an all-inclusive networked water disinfection system included in the purchase of the home. Pure H20 has developed and designed a point-of-use disinfection system primarily for hospital use. These systems provide the necessary added protection for cancer and other immune-compromised patients.

Stocks acting well as of late include: StemCells Inc. (NASDAQ: STEM), Cisco Systems Inc. (NASDAQ: CSCO), and Owens Corning (OTC BB: OWENQ).

Information contained herein is the opinion of ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Pure H20 Bio-Technologies, Inc. compensation from a third party shareholder: four million free trading shares of stock in Pure H20 Bio-Technologies, Inc., already delivered from a third party shareholder. To date, MP has sold three hundred thousand shares of stock in Pure H20 Bio-Technologies, Inc. for proceeds totaling one thousand seven hundred dollars. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.

Contact Information